期刊文献+

Changes in percentage of lymphocyte subsets after ^(131)I treatment in patients with differentiated thyroid cancer

Changes in percentage of lymphocyte subsets after ^(131)I treatment in patients with differentiated thyroid cancer
下载PDF
导出
摘要 To monitor the extent and the duration of lymphocyte subset changes in patients with thyroid carcinoma undergoing therapeutic 131I administration, the percentage of lymphocyte subsets were serially analyzed before and after 131I treatment. In patients who received 1850 MBq of 131I for ablation of thyroid remnants, only for NK cells and B cells showed a significant reduction. In patients received 3700 MBq of 131I for treatment of local lymph node me-tastases, NK cells, B cells and CD4+ were found decreased. In patients received 7400 MBq of 131I for treatment of distant metastases, NK cells, B cells and CD4+ and CD8+ were all affected. However, there is no significant reduc-tion compared to the baseline in the percentage of all lymphocyte subsets three months after 131I treatment. The re-sults show that the sensitivity of lymphocytes to 131I internal radiation depends upon lymphocyte phenotype and 131I activity. The immunosuppression effects are temporary and reversible. To monitor the extent and the duration of lymphocyte subset changes in patients with thyroid carcinoma undergoing therapeutic ^131I administration, the percentage of lymphocyte subsets were serially analyzed before and after ^131I treatment. In patients who received 1850 MBq of ^131I for ablation of thyroid remnants, only tor NK cells and B cells showed a significant reduction. In patients received 3700 MBq of ^131I for treatment of local lymph node metastases, NK cells, B cells and CD4+ were found decreased. In patients received 7400 MBq of ^131I for treatment of distant metastases, NK cells, B cells and CD4+ and CD8+ were all affected. However, there is no significant reduction compared to the baseline in the percentage of all lymphocyte subsets three months after ^131I treatment. The results show that the sensitivity of lymphocytes to ^131I internal radiation depends upon lymphocyte phenotype and ^131I activity. The immunosuppression effects are temporary and reversible.
出处 《Nuclear Science and Techniques》 SCIE CAS CSCD 2005年第4期214-216,共3页 核技术(英文)
基金 Supported by the Science and Technology Development Fund of Shanghai (No: 024119053)
关键词 淋巴细胞 ^131I 甲状腺 癌症 放射性疗法 抑制免抑反应 Differentiated thyroid cancer, Lymphocyte subsets, Iodine-131, Radiation therapy, Radionuclide
  • 相关文献

参考文献13

  • 1Leeper R. Thyroid Today. 1982, 4:1-6.
  • 2Van Nostrand D. Neutze J. Atkins E J Nucl Med. 1986,27:1519-1527.
  • 3Blomgven H, Petrini B, Wasserman J, et al. lnt J Radiat Oncol Biol Phys, 1987, 13:209-215.
  • 4Bushnell D L, Boles M A, Kaufman G E, et al. J Nucl Med, 1992, 33:2214-2221.
  • 5Tofani A, Sciuto R, Cioffi R P, et al. Eur J Nucl Med,1999, 26:824-829.
  • 6Tartter P I, Martinelli Ca Steinberg B, et al. Cancer Detect Prev, 1986, 9:359-364.
  • 7Brittenden J, Heys S D, Ross J, et al. Cancer, 1996, 77:1226-1243.
  • 8Ohashi H, Itoh M. Endocr Regul, 1994, 28:117-123.
  • 9Corrales J J, Orfao A, Mirrales J M, et al. Hormon Metab Res, 1994, 26:104-108.
  • 10Kasuga Y, Kobayashi S. Fuiimori M, et al. Eur J Surg,1998, 164:173-178.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部